| Lipids in Health and Disease | |
| Long term stability of paraoxonase-1 and high-density lipoprotein in human serum | |
| Eugène HJM Jansen1  Maryana Gorshunska2  Piet K Beekhof1  | |
| [1] Laboratory for Health Protection Research, National Institute of Public Health and the Environment, PO Box 1, Bilthoven, BA, 3720, The Netherlands;Department of Endocrinology, Kharkiv Postgraduate Medical Academy, Korchagintsiv Str., 58, Kharkiv, 61176, Ukraine | |
| 关键词: Storage; Stability; Serum; High-density lipoprotein; Paraoxonase; | |
| Others : 1160310 DOI : 10.1186/1476-511X-11-53 |
|
| received in 2012-01-16, accepted in 2012-05-04, 发布年份 2012 | |
PDF
|
|
【 摘 要 】
Background
Paraoxonase-1 (PON1) is an enzyme with numerous functions and receives an increasing interest in clinical and epidemiological studies. Sometimes samples are stored for longer periods at a certain temperature. Therefore the stability of PON1 activity must be checked and retained upon storage for longer periods.
Results
In this study the stability of PON1 activity has been tested in human serum samples during storage up to 12 months at 3 commonly used temperatures, -20°C, -70°C and −196°C. It was found that the stability of the PON1 activity is constant during 12 months of storage at −70°C and −196°C. Storage at −20°C resulted in a small but statistically significant decrease after 6 months to about 94% of its original value. Nonetheless, the rank order between the samples at T = 0 and 12 months remained the same. The same temperature dependence was found for the associated high-density lipoprotein.
Conclusions
It can be concluded that −70°C is the right temperature for storage to maintain the PON1 activity for at least one year. Storage at a lower temperature in liquid nitrogen (−196°C) is not necessary.
【 授权许可】
2012 Beekhof et al.; licensee BioMed Central Ltd.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 20150410101730788.pdf | 188KB | ||
| Figure 3. | 18KB | Image | |
| Figure 2. | 19KB | Image | |
| Figure 1. | 20KB | Image |
【 图 表 】
Figure 1.
Figure 2.
Figure 3.
【 参考文献 】
- [1]Furlong CE, Suzuki SM, Stevens RC, Marsillach J, Richter RJ, Jarvik GP, Checkoway H, Samii A, Costa LG, Griffith A, Roberts JW, Yearout D, Zabetian CP: Human PON1, a biomarker of risk of disease and exposure. Chem Biol Interact 2010, 187:355-361.
- [2]Tavori H, Rosenblat M, Vaya J, Aviram M: Paraoxonase 1 interactions with atherosclerotic lesions and arterial macrophages protect against foam cell formation and atherosclerosis development. Clinical Lipidology 2010, 5:685-697.
- [3]Camuzcuoglu H, Toy H, Cakir H, Celik H, Erel O: Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus. J Womens Health 2009, 18:1435-1439.
- [4]Gorshunskaya M, Karachentsev Y, Atramentova L, Tyzhnenko T, Kravchun N, Pochernyaev A, Poltorak V: Q192R polymorphism of PON-1 gene in type 2 diabetes patients. Cytol Genet 2011, 45:38-40.
- [5]van den Berg SW, Jansen EHJM, Kruijshoop M, Beekhof PK, Blaak E, van der Kallen CJ, van Greevenbroek MMJ, Feskens EJM: Paraoxonase 1–192 phenotype and lower paraoxonase 1 activity are associated with increased risk of Type 2 diabetes (the CODAM Study). Diabet Med 2008, 25:186-193.
- [6]Gugliucci A, Kinugasa E, Kotani K, Caccavello R, Kimura S: Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis. Clin Chem Lab Med 2011, 49:61-67.
- [7]Gaidukov L, Rosenblat M, Aviram M, Tawfik DS: The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation and cholesterol efflux. J Lipid Res 2006, 47:2492-2502.
- [8]Loued S, Isabelle M, Berrougui H, Khalil A: The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins. Life Sci 2012, 90:82-88.
- [9]Mackness M, Mackness B: Effect of dilution on high-density lipoprotein associated paraoxonase-1 activity. Clin Biochem 2011, 44:1270-1271.
- [10]Zafiropoulos A, Linardakis M, Jansen EHJM, Tsatsakis AM, Kafatos A, Tzanakakis GN: Paraoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue. J Lipid Res 2010, 51:1991-2000.
- [11]Huen K, Richter R, Furlong C, Eskenazi B, Holland N: Validation of PON1 enzyme activity assays for longitudinal studies. Clin Chim Acta 2009, 402:67-74.
- [12]van Himbergen TM, Roest M, de Graaf J, Jansen EHJM, Hattori H, Kastelein JJP, Voorbij HAM, Stalenhoef AFH, van Tits LJH: Indications that paraoxonase-1 contributes to plasma high-density lipoprotein levels in familial hypercholesterolemia. J Lipid Res 2005, 46:445-451.
PDF